4 Mutational signature evolution in oligoprogressive EML4-ALK fusion positive metastatic lung adenocarcinoma following brigatinib treatment – a representative case from the ENLItN Study: Eastern and Northwestern Lung cancer In Never-smokers cohort

Lung Cancer 2026

View at publisher
Authors: Maya Bienz, Helen Davies, Yasin Memari, Daniella Black, Mouhamad Hussein Ismail, Michael Luo, Sherine Ahmed, Shadi Basyuni, Siddhartha Kar, Serena Nik‐Zainal, Frank M. McCaughan
DOI: 10.1016/j.lungcan.2026.108954
Cited by: 0
References: 3

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
108954–108954
Publication date
1 February 2026
Language
EN